Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

Kansai Hepatobiliary Oncology Group200 enrolled

Overview

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Intrahepatic Cholangiocarcinoma

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Cases of major hepatectomy due to intrahepatic cholangiocarcinoma Exclusion Criteria: \-

Locations (1)

Osaka University, Graduate School of Medicine

Osaka, Osaka, Japan

Outcomes

Primary Outcomes

3-year recurrence-free survival rate

Time frame: 11 years (2000-2010)

Ratio of local recurrence at the hepatico-duodenal ligament

Time frame: 11 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.